SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,259,000 | -33.2% | 541,561 | -41.2% | 2.88% | -32.2% |
| Q4 2015 | $12,372,000 | -14.2% | 920,550 | -10.5% | 4.24% | -14.4% |
| Q3 2015 | $14,427,000 | -54.7% | 1,028,304 | -45.2% | 4.96% | -50.3% |
| Q2 2015 | $31,841,000 | -0.4% | 1,875,227 | -29.1% | 9.98% | -19.0% |
| Q1 2015 | $31,973,000 | +24.4% | 2,644,571 | -14.6% | 12.32% | +24.7% |
| Q4 2014 | $25,693,000 | +2.1% | 3,095,589 | +6.9% | 9.88% | +13.4% |
| Q3 2014 | $25,168,000 | -8.3% | 2,896,222 | +15.6% | 8.71% | -0.2% |
| Q2 2014 | $27,444,000 | +128.2% | 2,506,346 | +86.3% | 8.73% | +144.9% |
| Q1 2014 | $12,025,000 | – | 1,345,031 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |